Sequential Treatments or Combinations Including Dasatinib, Quercetin, Fisetin and/or Temozolomide for the Treatment of Previously Treated Glioma With Residual Disease
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Related studies linked through entity extraction aliases.